Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Curr Opin Immunol. 2021 Nov 15;74:68–75. doi: 10.1016/j.coi.2021.10.005

Cellular interactions in resident memory T cell establishment and function

Mohammad H Hasan 1, Lalit K Beura 1,*
PMCID: PMC8901561  NIHMSID: NIHMS1752873  PMID: 34794039

Abstract

Tissue resident memory T cells (TRM) are enriched in non-lymphoid tissues and represent a formidable barrier against invading pathogens and tumors. TRM are armed with deployment ready effector molecules which combined with their frontline location allows them to be early organizing centers of our immune defense. Despite their autonomous nature, TRM rely on careful collaboration with other immune and non-immune cells located within the barrier organ to exert their superior protective role. Here, we highlight recent studies focusing on cellular interactions that regulate TRM establishment and function. A deeper understanding of these processes is instrumental in designing new means to target TRM for desirable outcomes in infectious diseases, cancers and autoimmunity.

Keywords: Resident memory T cells (TRM), Immunosurveillance, intercellular communications, cytokines, TRM survival and maintenance, TRM reactivation, effector function, plasticity

Introduction

The realization that a large fraction of memory T cells in our body are stably contained within non-lymphoid tissues (NLTs) and are not routinely circulating, has brought a remarkable shift in our understanding of immunological memory. Resident memory T cells (TRM) are now considered the numerically dominant memory T cells in most peripheral organs [1,2]. The numerical abundance of TRM in barrier tissue is coupled with their rapidity of effector functions upon reencounter with antigen. In a study that sampled herpes simplex virus-2 (HSV-2) reactivation every 6hr, it was shown that the presence of local TRM rapidly limited viral replication within 24hrs of initial viral recrudescence [3]. While TRM’s protective role was initially described in the setting of viral infections, recent studies have broadened their antipathogenic capabilities to cover numerous bacterial and fungal diseases as well as cancers. Spatially, an individual resident cell patrols a limited territory, but considering all TRM together, they comprise a highly effective network that can be rapidly mobilized against an incoming pathogen [4,5]. As such, density of TRM is directly linked to their protective ability. Our understanding of TRM’s functional capabilities is undergoing tremendous expansion. It was recently demonstrated that CD8 TRM are a key player in establishing cancer-immune equilibrium through their expression of effector molecule TNF in a mouse model of melanoma [6]. This is suggestive of a highly effective and durable immunosurveillance activity that may span decades.

Immunosurveillance activities of TRM in non-barrier organs has also received significant attention recently. The liver of individuals infected with Hepatitis B virus has been shown to harbor a unique population of IL-2high CD8 TRM that could exert partial control of the virus [7]. Similarly, in a mouse model of malaria, liver TRM were instrumental in patrolling the sinusoids and providing protection against sporozoite replication [8]. Additionally, TRM in brain have been shown to control fatal viral encephalitis in multiple contexts [9,10]. While these potent effector functions are responsible for accelerated clearance of pathogens, they also indicate TRM’s potential for harm. TRM are likely central to the pathogenesis of numerous chronic inflammatory diseases and recent work by Steinbach et al, suggests presence of brain TRM early in life can indeed potentiate the development of autoimmune lesions in the central nervous system [11].

While the potent anti-pathogenic as well as pathologic roles of TRM are well established, the cellular interactions that underpin TRM fate decisions, differentiation and functions are less well understood. Here we review the current state of the field emphasizing the cellular circuitry that modulate these processes.

TRM differentiation and maintenance

As part of the anti-pathogen effector response, TRM precursors gain entrance to non-lymphoid tissues (NLTs) to eliminate infection. Although these TRM precursors are phenotypically similar to KLRG1lo memory precursor effector cells that give rise to long-lived circulating memory T cells, recent studies have identified important transcriptional differences [12]. Even at this early stage in memory differentiation, many TRM precursors in NLTs already adopt transcriptional and epigenetic features of mature TRM. By combining lineage tracing and single cell transcriptomic analysis approaches, recent studies have identified the presence of committed TRM precursors within the effector CD8 T cell pool with increased level of TRM- associated genes in the blood or target NLTs [13,14].

Early TRM programming

While the specification of the early TRM fate is a product of the integrating a diverse array of T cell-intrinsic and extrinsic signals, most research has focused so far on investigating T cell-specific transcriptional regulators that impact TRM formation (comprehensively reviewed in [15,16]). Identifying external cues and their cellular sources that may impact early TRM fate decisions will be crucial to modulate their abundance and functionality. A recent study by Mani et al, showed that migratory dendritic cells can precondition naïve CD8 T cells towards an epidermal TRM fate through TGF-β [17]. Such homeostatic programming even before T cells are activated, suggests a significant heterogeneity in the TRM-differentiation potential of the pre-immune T cell repertoire. Studies in mouse models of influenza and vaccinia virus infection suggest a critical role of DNGR-1+ dendritic cells (DCs) in priming TRM precursors [18]. These cross-priming DCs produce cytokines IL-12 and IL-15 which along with molecule CD24 are required for optimal priming of TRM precursors. IL-6 produced by fibroblastic reticular cells was shown to enhance T cell survival and promote TRM differentiation [19]. Similarly, monocytes derived IL-10 was important in lung TRM differentiation [20]. As more tools become available to temporally manipulate the priming environment of T cells, the identity of additional molecules and cellular interactions that underpin acquisition of TRM fate will be revealed.

TRM differentiation and maintenance in non-lymphoid tissues

Once in the target tissue, CD8 TRM precursors undergo further differentiation under the influence of the local environment. Cells in the NLTs can influence entry of TRM precursors, their accurate positioning and ultimately their immunosurveillance activities during steady state as well as after secondary infection.

a). CD4 T cells:

CD4 T cell help is important for functional long-lived memory CD8 T cells but is dispensable for effector CD8 T cell generation. In contrast, TRM differentiation requires CD4 T cell help in several viral infection models. Upon HSV-2 infection effector CD8 T cell migration to the female genital mucosa required CD4 T cell derived IFN-γ [21]. However, this migratory defect was not observed in systemic and intracranial lymphocytic choriomeningitis infection, vaccinia virus skin infection and human papilloma virus vector immunization [9,22-24]. This suggests a highly pathogen specific role of CD4 T cells in creating a TRM permissive environment. In the context of influenza infection of respiratory mucosa, CD4 T cell deficiency was shown to impair formation of CD103+ CD8 TRM [25]. Although there was no migrational defect, the CD8 TRM were localized away from airways and had poor protective ability against heterosubtypic infection. A recent report suggests that T-bet expressing type-1 regulatory T cells improve TGF-β bioavailability and promote CD8 TRM establishment through expression of integrin β8 by the Treg cells [26]. In the context of persistent murine polyoma virus infection, IL-21 from CD4 follicular helper-like T cells has been shown to be important for brain CD8 TRM differentiation [27]. A similar mechanism has also been proposed for acute influenza virus infection [28]. Importantly this help was not only needed for CD8 TRM positioning but also their recall function.

b). Immune cell aggregates:

TRM in the female reproductive mucosa and skin have been shown to be present in “cluster” with other T cells and professional antigen-presenting cells (APCs) (Fig. 1a) [29,30]. These memory lymphocyte clusters (MLCs) are distinct from tertiary lymphoid organs (TLOs) but thought to play a similar critical role in initiating early responses against reinfections. The chemokine CCL5 derived from the APCs or CD8 T cells is important for maintenance of CD4 TRM within these microanatomical niches. CCL5 expression in turn is maintained via a positive feedback loop by low level IFN-γ produced by TRM cells present within the MLCs. Similarly in influenza infection, CD4 TRMs are maintained within TLOs termed inducible bronchus-associated lymphoid tissues where they promote survival and function of CD8 TRM as well as resident B cells (Fig. 1b) [28,31].

Figure 1. Cells in diverse anatomic niches supporting TRM maintenance.

Figure 1.

(A) TRM in skin. CD8 TRM in the skin epidermis require TGF-β for its appropriate differentiation and long-term maintenance. The source of this TGF-β is the CD8 TRM itself but for the activation of the latent TGF-β, TRM rely on integrin αvβ6 and αvβ8 found on surrounding keratinocytes. Both CD4 TRM and CD8 TRM also require IL-15 and IL-7 produced by the cells in hair follicle for their maintenance. CD4 TRM in the skin dermis are found in aggregates with CD11b+ macrophages and CD8 TRM. Similar memory lymphocyte clusters are found in the female reproductive tract (FRT) as well. But unlike FRT, where these clusters are maintained by CCL-5 produced by macrophages, in skin, the CD8 TRM are the source of CCL-5 and influence long-term maintenance of the CD4 TRM in this unique memory niche. (B) TRM in lung. CD4 helper TRM colocalize with resident B cells and CD8 TRM within the inducible bronchus-associated lymphoid tissues (iBALT) found in the lung. The CD4 TRM rely on autocrine IL-2 for survival as well as IL-7 and IL-15. They in turn provide IL-21 which influence positioning, survival and function of CD8 TRM. CD4 TRM also potentiate function of locally resident B cells in the tissue and enhance their survival through co-stimulatory interactions mediated by CD40L. HEV, high endothelial venule.

c). Myeloid cells:

Differentiation and long-term persistence of CD8 TRM are also regulated by other hematopoietic cells. Inflammatory monocytes recruited to the lamina propria of small intestine during Yersinia pseudotuberculosis infection were shown to be important for CD103neg CD8 TRM differentiation [32]. Lung alveolar macrophages can negatively regulate CD8 TRM abundance whereas pulmonary monocytes promote TRM differentiation after influenza infection [33,34]. Macrophages in the salivary gland were shown to be critical to the routine immunosurveillance of the organ at steady state by CD8 TRM [35].

d). Non-hematopoietic cells:

Stromal cells also provide critical survival factors required for TRM maintenance. In the skin epidermis, keratinocytes regulate TRM differentiation and maintenance [36]. Keratinocytes in the skin and epithelial cells in the small intestinal mucosa express TGF-β activating integrins αvβ6 and/or αvβ8. Ablation of these integrins interfered with long-term maintenance of TRM in skin epidermis and small intestine epithelium. Interestingly a recent study showed that the source of TGF- β are the CD8 TRM themselves not keratinocytes (Fig.1a) [37]. The reliance of epidermal TRM on TGF- β is continuous, as established TRM are depleted by blocking this signaling axis [36]. Competition for active TGF-β has been proposed to be a mechanism to selectively enrich antigen-specific TRM abundance in skin epidermis. Besides TGF-β, the production of cytokines IL-7 and IL-15 by cells in the hair follicle is also important for the localization and maintenance of both CD4 and CD8 TRM [38,39]. However, these cytokine requirements appear to be organ-specific as a number of tissues can support TRM in the absence of IL-15 [40]. Identification of tissue-specific survival signals and their cellular sources will be key towards devising new therapeutic means to alter TRM density in NLTs.

TRM reactivation

After antigen reencounter, TRM elaborate an array of effector functions to rapidly eliminate invading pathogens. While the initial response follows the classic T cell receptor activation, many of the downstream anti-pathogenic responses involve collaborative interactions with other cells present locally or in central circulation.

Sensing and alarm function

Upon reactivation both CD8 and CD4 TRM rapidly release copious amounts of effector cytokines and chemokines including IFN-γ, TNF-α, CCL-3 and CCL-4 [29,41-43]. The speed of this response often rivals that of innate immune cells and is possible because of the transcriptionally poised state of TRM ready to translate these effector molecules [39,44,45]. Besides inflammatory cytokines, most mucosal TRM also carry preformed cytotoxic granules including granzyme-B and perforin. While the ex vivo cytolytic activity of TRM is well established, evidence of in vivo cytotoxicity has only been shown in a few studies [9,46]. It is worth noting that a non-cytolytic purging of infection has the added advantage of maintaining the integrity of the vital organs and allows for a rapid return to homeostasis.

Besides their direct anti-pathogenic roles, TRM-elicited cytokines and chemokines help to broadcast the alarm signal to cells in the surrounding tissue. TRM induced IFN-γ upregulates VCAM-1 on adjacent endothelial cells as well as chemokines CXCL-9 and CXCL-10 that allow for fast recruitment of T and B lymphocytes from the periphery (Fig.2)[47]. These recruited memory B cells were the chief source of virus-specific antibodies in the reproductive mucosa in an HSV-2 infection model [48]. Interestingly in a recent simian-human immunodeficiency virus vaccine study in macaques, the presence of TRM in the genital tissue reduced the threshold of neutralizing antibody required for protection [49]. Whether this protection was mediated through actions of TRM-recruited antibodies is not known, but this finding underscores the potential synergy between local TRM and antibody responses.

Figure 2. Immune interactions after TRM reactivation.

Figure 2.

Restimulated TRM accelerate pathogen clearance through a range of direct and indirect actions. (1) CD8 TRM mediate the killing of infected cells via elaboration of cytotoxic granules perforin and granzyme-B. (2) Cytokines and chemokines secreted by the TRM, influence activation of local innate and adaptive immune cells as well as promote recruitment of B cells and T cells from the peripheral circulation. These recruited cells further aid in pathogen elimination through secretion of effector molecules including antibodies. (3) In situ proliferation of TRM generate new effectors to fight infections. (4) Some of these TRM progeny give rise to local secondary TRM after elimination of the infection. But a small group of cells can egress out of the tissue and redifferentiate to become circulating TCM or TEM.

TRM induced TNF-α and IL-2 are critical for maturation of dendritic cells and induction of granzyme-B among natural killer as well as bystander CD8 T cells respectively [47]. Activation of other immune cells in the affected organ combined with recruitment of cells from circulation contributes to the rapid control of the pathogen. In the case of cutaneous leishmaniasis, recruited inflammatory monocytes were a principal mechanism of parasite control through their production of reactive oxygen species and nitric oxide [50]. In a similar but pathologic context, resensitization of Th2 TRM in allergic airway disease led to activation of eosinophils in the airway and mucus metaplasia [51].

CD8 TRM display significant promiscuity in their ability to be activated by various types of APCs. Interestingly the quality of the TRM’s functional response can be modulated by the identity of APCs. In an influenza recall infection, it was recently shown that antigen-presentation by hematopoietic cells reduced the expression of TRM induced cytokines and chemokines [52]. By contrast non-hematopoietic cell mediated antigen presentation resulted in restraining of type-1 interferon stimulated gene (ISG) program and upregulation of cell cycle genes. This suggests that by focusing antigen-presentation to different compartments, one can tune TRM functionality.

In situ proliferation and developmental plasticity

In addition to their immediate effector functions, restimulated TRM undergo in situ proliferation and provide a new wave of activated T cells to rapidly contain pathogen spread [53,54]. After clearance of the pathogen, a number of these cells further differentiate into long-lived secondary TRM and increase TRM density in the local tissue. However, recent work suggests some TRM progeny do not necessarily adopt the TRM fate and rather exit from the NLT, enter systemic circulation and resemble central or effector memory T cells [55-58]. These so called ex-TRM cells retain transcriptional and epigenetic marks of their prior TRM-self and display migrational bias to their tissue of origin. Similar evidence of migrational plasticity has also been described in a small population of blood borne human CD4 T cells bearing canonical epithelial TRM marker, CD103 [59]. Importantly these cells show significant overlap in their transcriptome and TCR clonotype with bonafide TRM and maintain the ability to migrate and establish residence in human skin xenografts. Such migrational flexibility are likely to be critical in exerting TRM associated functions (both good and bad) in distant sites that are not seeded during primary immune responses. However, it is unknown how TRM progenies decide to become TRM again or escape the resident fate. Single cell RNA-seq studies have suggested significant heterogeneity among TRM populations. TRM cells expressing higher levels of CD28 and the transcription factor Id3 exhibit enhanced capacity to produce circulating memory T cells [14,60]. Such heterogeneity is well established during primary T cell response. Whether similar cellular program control the heterogenous fate of TRM progenies is an ongoing area of study and their identification will greatly improve our understanding of TRM biology.

Restraining TRM functions

Positioning of highly weaponized T cells in vital organs also raises issues of their aberrant activation leading to immunopathology. Accordingly, many TRM express molecules that can attenuate activation including the regulatory cytokine IL-10 and a whole range of co-inhibitory molecules. Most human and mouse TRM express PD-1, Tim-3, CTLA-4 and CD101 in the absence of persistent antigen [45,61]. Most often, the presence of these markers does not limit the functional responsiveness of TRM suggesting that the receptors are not actively engaged but nonetheless available for regulation. An example of such regulatory control is seen in influenza infection where PD1 expression by a population of lung TRM was shown to limit the latter’s inflammatory actions that might contribute to fibrosis [62]. Similarly, ex vivo characterization of human pancreatic tissue revealed that the effector functions of pancreatic CD8 TRMs are attenuated by resident macrophages through PD-1/PD-L1 pathways [63]. Interestingly during murine polyomavirus infection, interaction between PD-L1 expressing myeloid cells and PD-1+ CD8 TRM show examples of temporal regulation. The signaling is important to limit neuroinflammation during acute infection but is needed to maintain a certain level of inflammation to control virus during persistent infection [64].

Conclusions

Research over the last decade has positioned TRM as central in our anti-pathogen defense arsenal. However, TRM do not operate in isolation and must adapt to the physical, metabolic, and environmental constraints of their location. They make strange bedfellows with neighboring keratinocytes, pneumocytes, neurons, and other resident immune cells, all within the confines of a dense extracellular matrix. They are transcriptionally distinct from circulating memory T cells and based on their tissue location, display considerable heterogeneity in their maintenance requirements and functions. This is reflective of their tissue-specific adaptation that builds upon complex local interactions with numerous immune and non-immune cells. We have just begun to unravel the crosstalk that occurs between TRM and other cell types using classical immunology approaches. High throughput next-generation technologies could significantly propel these discoveries and build a comprehensive map of cellular interactions underlying every aspect of TRM biology.

Highlights.

  • Resident memory T cell (TRM) differentiation and function is dependent on a number of extracellular interactions

  • Through secretion of cytokines, chemokines and other immune mediators, these cells can influence generation of TRM precursors, migration of TRM to target tissue and their long-term residence

  • Upon TRM reactivation after pathogen encounter, TRM engages the local antipathogenic cells to rapidly curtail pathogen spread

Acknowledgements

This work was supported by National Institute of Health grants (P20GM121298 and P20GM109035) and Searle Scholars Foundation. We thank Drs Sathi Wijeyesinghe, Emily A. Thompson and Brandon J. Burbach for critical reading of the manuscript. The authors apologize in advance to colleagues whose work could not be cited because of space limitations.

Footnotes

Declaration of interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

Papers of particular interest, published within the period of review, have been highlighted as:

• of special interest

•• of outstanding interest

  • 1.Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, Igyártó BZ, Southern PJ, Masopust D: Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 2015, 161:737–749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kumar B V, Connors TJ, Farber DL: Human T Cell Development, Localization, and Function throughout Life. Immunity 2018, 48:202–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Roychoudhury P, Swan DA, Duke E, Corey L, Zhu J, Davé V, Spuhler LR, Lund JM, Prlic M, Schiffer JT: Tissue-resident T cell-derived cytokines eliminate herpes simplex virus-2-infected cells. J Clin Invest 2020, 130:2903–2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zaid A, Mackay LK, Rahimpour A, Braun A, Veldhoen M, Carbone FR, Manton JH, Heath WR, Mueller SN: Persistence of skin-resident memory T cells within an epidermal niche. Proc Natl Acad Sci 2014, 111:5307–5312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Thompson EA, Mitchell JS, Beura LK, Torres DJ, Mrass P, Pierson MJ, Cannon JL, Masopust D, Fife BT, Vezys V: Interstitial Migration of CD8αβ T Cells in the Small Intestine Is Dynamic and Is Dictated by Environmental Cues. Cell Rep 2019, doi: 10.1016/j.celrep.2019.02.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Park SL, Buzzai A, Rautela J, Hor JL, Hochheiser K, Effern M, McBain N, Wagner T, Edwards J, McConville R, et al. : Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin. Nature 2019, 565:366–371. [DOI] [PubMed] [Google Scholar]
  • 7.Pallett LJ, Davies J, Colbeck EJ, Robertson F, Hansi N, Easom NJW, Burton AR, Stegmann KA, Schurich A, Swadling L, et al. : IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection. J Exp Med 2017, 214:1567–1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fernandez-Ruiz D, Ng WY, Holz LE, Ma JZ, Zaid A, Wong YC, Lau LS, Mollard V, Cozijnsen A, Collins N, et al. : Liver-Resident Memory CD8 + T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection. Immunity 2016, 45:889–902. [DOI] [PubMed] [Google Scholar]
  • 9.Steinbach K, Vincenti I, Kreutzfeldt M, Page N, Muschaweckh A, Wagner I, Drexler I, Pinschewer D, Korn T, Merkler D: Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infection. J Exp Med 2016, 213:1571–1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Urban SL, Jensen IJ, Shan Q, Pewe LL, Xue H, Badovinac VP, Harty JT: Peripherally induced brain tissue–resident memory CD8+ T cells mediate protection against CNS infection. Nat Immunol 2020, 21:938–949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Steinbach K, Vincenti I, Egervari K, Kreutzfeldt M, van der Meer F, Page N, Klimek B, Rossitto-Borlat I, Di Liberto G, Muschaweckh A, et al. : Brain-resident memory T cells generated early in life predispose to autoimmune disease in mice. Sci Transl Med 2019, 11:eaav5519. [DOI] [PubMed] [Google Scholar]
  • 12.Milner JJ, Toma C, Yu B, Zhang K, Omilusik K, Phan AT, Wang D, Getzler AJ, Nguyen T, Crotty S, et al. : Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours. Nature 2017, 552:253–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • .13. Kok L, Dijkgraaf FE, Urbanus J, Bresser K, Vredevoogd DW, Cardoso RF, Perié L, Beltman JB, Schumacher TN: A committed tissue-resident memory T cell precursor within the circulating CD8+ effector T cell pool. J Exp Med 2020, 217. By using lineage tracing and single-cell transcriptional analysis this study identified a pool of effector CD8 T cells in blood with enriched expression of TRM-associated genes that give rise to TRM in tissues.
  • •14. Kurd NS, He Z, Louis TL, Milner JJ, Omilusik KD, Jin W, Tsai MS, Widjaja CE, Kanbar JN, Olvera JG, et al. : Early precursors and molecular determinants of tissue-resident memory CD8 + T lymphocytes revealed by single-cell RNA sequencing. Sci Immunol 2020, 5:eaaz6894. By using lineage tracing and single-cell transcriptional analysis this study identified a pool of effector CD8 T cells in blood with enriched expression of TRM-associated genes that give rise to TRM in tissues.
  • 15.Milner JJ, Goldrath AW: Transcriptional programming of tissue-resident memory CD8+ T cells. Curr Opin Immunol 2018, 51:162–169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mackay LK, Kallies A: Transcriptional Regulation of Tissue-Resident Lymphocytes. Trends Immunol 2016, xx:1–10. [DOI] [PubMed] [Google Scholar]
  • ..17. Mani V, Bromley SK, Äijö T, Mora-Buch R, Carrizosa E, Warner RD, Hamze M, Sen DR, Chasse AY, Lorant A, et al. : Migratory DCs activate TGF-β to precondition naïve CD8+ T cells for tissue-resident memory fate. Science 2019, 366. This study identified a critical role of migratory dendritic cells in biasing naïve T cells for epidermal TRM fate through TGF-β mediated preconditioning.
  • .18. Iborra S, Martínez-López M, Khouili SC, Enamorado M, Cueto FJ, Conde-Garrosa R, del Fresno C, Sancho D: Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1+Dendritic Cells. Immunity 2016, 45:847–860. These authors reported a significant role of DNGR1+ dendritic cells in priming TRM fate among activated T cells in the lymph node.
  • 19.Brown FD, Sen DR, LaFleur MW, Godec J, Lukacs-Kornek V, Schildberg FA, Kim HJ, Yates KB, Ricoult SJH, Bi K, et al. : Fibroblastic reticular cells enhance T cell metabolism and survival via epigenetic remodeling. Nat Immunol 2019, 20:1668–1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Thompson EA, Darrah PA, Foulds KE, Hoffer E, Caffrey-Carr A, Norenstedt S, Perbeck L, Seder RA, Kedl RM, Loré K: Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-β Release. Cell Rep 2019, 28:1127–1135.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Nakanishi Y, Lu B, Gerard C, Iwasaki A: CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help. Nature 2009, 462:510–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Beura LK, Mitchell JS, Thompson EA, Schenkel JM, Mohammed J, Wijeyesinghe S, Fonseca R, Burbach BJ, Hickman HD, Vezys V, et al. : Intravital mucosal imaging of CD8+ resident memory T cells shows tissue-autonomous recall responses that amplify secondary memory. Nat Immunol 2018, 19:173–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Jiang X, Clark R a., Liu L, Wagers AJ, Fuhlbrigge RC, Kupper TS: Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature 2012, 483:227–231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Çuburu N, Kim R, Guittard GC, Thompson CD, Day PM, Hamm DE, Pang Y-YS, Graham BS, Lowy DR, Schiller JT: A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8 + Memory T Cells. J Immunol 2019, 202:1250–1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Laidlaw BJ, Zhang N, Marshall HD, Staron MM, Guan T, Hu Y, Cauley LS, Craft J, Kaech SM: CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells during Influenza Viral Infection. Immunity 2014, 41:633–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Ferreira C, Barros L, Baptista M, Blankenhaus B, Barros A, Figueiredo-Campos P, Konjar Š, Lainé A, Kamenjarin N, Stojanovic A, et al. : Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells. Nat Immunol 2020, doi: 10.1038/s41590-020-0674-9. [DOI] [PubMed] [Google Scholar]
  • .27. Ren HM, Kolawole EM, Ren M, Jin G, Netherby-Winslow CS, Wade Q, Shwetank, Rahman ZSM, Evavold BD, Lukacher AE: IL-21 from high-affinity CD4 T cells drives differentiation of brain-resident CD8 T cells during persistent viral infection. Sci Immunol 2020, 5:eabb5590. This study identified a critical cellular interaction involving IL-21 from CD4 T cells and IL21 receptor expressing CD8 TRM in polyoma virus infection that is required for brain TRM maintainance and function.
  • .28. Son YM, Cheon IS, Wu Y, Li C, Wang Z, Gao X, Chen Y, Takahashi Y, Fu Y-X, Dent AL, et al. : Tissue-resident CD4 + T helper cells assist the development of protective respiratory B and CD8 + T cell memory responses. Sci Immunol 2021, 6:eabb6852. This work uncovered the presence of tissue resident CD4 helper T cells in lung that help both CD8 TRM and resident B cell anti-influenza immune responses.
  • 29.Iijima N, Iwasaki A, Sallusto F, Lenig D, Förster R, Lipp M, Lanzavecchia A, Wherry EJ, Teichgräber V, Becker TC, et al. : T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 2014, 346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Collins N, Jiang X, Zaid A, Macleod BL, Li J, Park CO, Haque A, Bedoui S, Heath WR, Mueller SN, et al. : Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nat Commun 2016, 7:11514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • .31. Swarnalekha N, Schreiner D, Litzler LC, Iftikhar S, Kirchmeier D, Künzli M, Son YM, Sun J, Moreira EA, King CG: T resident helper cells promote humoral responses in the lung. Sci Immunol 2021, 6808. Similar to reference 28, these authors identified central importance of resident CD4 TRM in anti-flu antibody responses.
  • 32.Bergsbaken T, Bevan MJ, Fink PJ: Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue-Resident Memory T Cells. Cell Rep 2017, 19:114–124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Goplen NP, Huang S, Zhu B, Cheon IS, Son YM, Wang Z, Li C, Dai Q, Jiang L, Sun J: Tissue-Resident Macrophages Limit Pulmonary CD8 Resident Memory T Cell Establishment. Front Immunol 2019, 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dunbar PR, Cartwright EK, Wein AN, Tsukamoto T, Tiger Li ZR, Kumar N, Uddbäck IE, Hayward SL, Ueha S, Takamura S, et al. : Pulmonary monocytes interact with effector T cells in the lung tissue to drive TRM differentiation following viral infection. Mucosal Immunol 2020, 13:161–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Stolp B, Thelen F, Ficht X, Altenburger LM, Ruef N, Inavalli VVGK, Germann P, Page N, Moalli F, Raimondi A, et al. : Salivary gland macrophages and tissue-resident CD8 + T cells cooperate for homeostatic organ surveillance. Sci Immunol 2020, 5:eaaz4371. [DOI] [PubMed] [Google Scholar]
  • 36.Mohammed J, Beura LK, Bobr A, Astry B, Chicoine B, Kashem SW, Welty NE, Igyártó BZ, Wijeyesinghe S, Thompson EA, et al. : Stromal cells control the epithelial residence of DCs and memory T cells by regulated activation of TGF-β. Nat Immunol 2016, 17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • ..37. Hirai T, Yang Y, Zenke Y, Li H, Chaudhri VK, De La Cruz Diaz JS, Zhou PY, Nguyen BA-T, Bartholin L, Workman CJ, et al. : Competition for Active TGFβ Cytokine Allows for Selective Retention of Antigen-Specific Tissue- Resident Memory T Cells in the Epidermal Niche. Immunity 2021, 54:84–98.e5. This report demonstrated that the source of TGF-β in skin is TRM itself and the competition for active TGF-β is a mean to enrich antigen-specific TRM in the skin.
  • 38.Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, Saya H, Amagai M, Nagao K: Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med 2015, 21:1272–1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon M-L, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, et al. : The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol 2013, 14:1294–301. [DOI] [PubMed] [Google Scholar]
  • 40.Schenkel JM, Fraser KA, Casey KA, Beura LK, Pauken KE, Vezys V, Masopust D: IL-40.15–Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. J Immunol 2016, 196:3920–3926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Schenkel JM, Fraser KA, Vezys V, Masopust D: Sensing and alarm function of resident memory CD8(+) T cells. Nat Immunol 2013, 14:509–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Beura LK, Fares-Frederickson NJ, Steinert EM, Scott MC, Thompson EA, Fraser KA, Schenkel JM, Vezys V, Masopust D: CD4+ resident memory T cells dominate immunosurveillance and orchestrate local recall responses. J Exp Med 2019, 216:1214–1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ariotti S, Hogenbirk MA, Dijkgraaf FE, Visser LL, Hoekstra ME, Song J-Y, Jacobs H, Haanen JB, Schumacher TN: Skin-resident memory CD8 + T cells trigger a state of tissue-wide pathogen alert. Science (80- ) 2014, 346:101–105. [DOI] [PubMed] [Google Scholar]
  • 44.Hombrink P, Helbig C, Backer RA, Piet B, Oja AE, Stark R, Brasser G, Jongejan A, Jonkers RE, Nota B, et al. : Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nat Immunol 2016, 18:246–246. [DOI] [PubMed] [Google Scholar]
  • 45.Kumar B V, Ma W, Miron M, Friedman AL, Shen Y, Farber DL, Granot T, Guyer RS, Carpenter DJ, Senda T, et al. : Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites. Cell Rep 2017, 20:2921–2934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A, et al. : Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature 2013, 497:494–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D: Resident memory CD81 cells trigger protective innate and adaptive immune responses. Science (80- ) 2014, 346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Oh JE, Iijima N, Song E, Lu P, Klein J, Jiang R, Kleinstein SH, Iwasaki A: Migrant memory B cells secrete luminal antibody in the vagina. Nature 2019, doi: 10.1038/s41586-019-1285-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Arunachalam PS, Charles TP, Joag V, Bollimpelli VS, Scott MKD, Wimmers F, Burton SL, Labranche CC, Petitdemange C, Gangadhara S, et al. : T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers. Nat Med 2020, 26:932–940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Glennie ND, Volk SW, Scott P: Skin-resident CD4+T cells protect against Leishmania major by recruiting and activating inflammatory monocytes. PLoS Pathog 2017, 13:1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Rahimi RA, Nepal K, Cetinbas M, Sadreyev RI, Luster AD: Distinct functions of tissue-resident and circulating memory Th2 cells in allergic airway disease. J Exp Med 2020, 217:2020.03.25.006858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • ..52. Low JS, Farsakoglu Y, Amezcua Vesely MC, Sefik E, Kelly JB, Harman CCD, Jackson R, Shyer JA, Jiang X, Cauley LS, et al. : Tissue-resident memory T cell reactivation by diverse antigen-presenting cells imparts distinct functional responses. J Exp Med 2020, 217. By using transcriptional analysis this study suggested that distinct TRM functional outputs can be achieved by targeting antigen presentation to hematopoietic vs non-hematopoietic compartment.
  • 53.Beura LK, Mitchell JS, Thompson EA, Schenkel JM, Mohammed J, Wijeyesinghe S, Fonseca R, Burbach BJ, Hickman HD, Vezys V, et al. : Intravital mucosal imaging of resident memory CD8+ T cell shows tissue-autonomous recall responses that amplify secondary memory. Nat Immunol 2018, doi: 10.1038/s41590-017-0029-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Park SL, Zaid A, Hor JL, Christo SN, Prier JE, Davies B, Alexandre YO, Gregory JL, Russell TA, Gebhardt T, et al. : Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses. Nat Immunol 2018, 19:183–191. [DOI] [PubMed] [Google Scholar]
  • .55. Fonseca R, Beura LK, Quarnstrom CF, Ghoneim HE, Fan Y, Zebley CC, Scott MC, Fares-Frederickson NJ, Wijeyesinghe S, Thompson EA, et al. : Developmental plasticity allows outside-in immune responses by resident memory T cells. Nat Immunol 2020. 21:412—421. Through adoptive transfers and long-term fate tracking this study demonstrated thatrestimulated TRM exhibit developmental plasticity and can adopt features of circulating memory T cells while maintaining a migrational bias to their tissue of origin.
  • .56. Behr FM, Parga-Vidal L, Kragten NAM, van Dam TJP, Wesselink TH, Sheridan BS, Arens R, van Lier RAW, Stark R, van Gisbergen KPJM: Tissue-resident memory CD8+ T cells shape local and systemic secondary T cell responses. Nat Immunol 2020, 21:1070–1081. By using a Hobit-fate mapping mouse these authors reported th ability of TRM progenies to form circulating memory T cells with systemic immunosurveillance activities.
  • 57.Christo SN, Evrard M, Park SL, Gandolfo LC, Burn TN, Fonseca R, Newman DM, Alexandre YO, Collins N, Zamudio NM, et al. : Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity. Nat Immunol 2020. doi: 10.1038/s41590-021-01004-1. [DOI] [PubMed] [Google Scholar]
  • 58.Wijeyesinghe S, Beura LK, Pierson MJ, Stolley JM, Adam OA, Ruscher R, Steinert EM, Rosato PC, Vezys V, Masopust D: Expansible residence decentralizes immune homeostasis. Nature 2021, doi: 10.1038/s41586-021-03351-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • .59. Klicznik MM, Morawski PA, Höllbacher B, Varkhande SR, Motley SJ, Kuri-Cervantes L, Goodwin E, Rosenblum MD, Long SA, Brachtl G, et al. : Human CD4 + CD103 + cutaneous resident memory T cells are found in the circulation of healthy individuals. Sci Immunol 2019, 4:eaav8995. Using human skin xenograft model, this study reported presence of CD103+ CD4 T cells in blood derived from cutaneous CD4 TRM with substantial clonal, transcriptional and functional overlap between the two populations.
  • .60. Milner JJ, Toma C, He Z, Kurd NS, Nguyen QP, McDonald B, Quezada L, Widjaja CE, Witherden DA, Crowl JT, et al. : Heterogenous Populations of Tissue-Resident CD8+ T Cells Are Generated in Response to Infection and Malignancy. Immunity 2020, 52:808–824.e7. This study revealed an unappreciated heterogeneity among TRM in small intestine epithelium, based on transcription factors Id2 and Id3 with distinct functional potential and developmental trajectories.
  • 61.Mackay LK, Minnich M, Kragten NAM, Liao Y, Nota B, Seillet C, Zaid A, Man K, Preston S, Freestone D, et al. : Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science (80- ) 2016, 352:459–463. [DOI] [PubMed] [Google Scholar]
  • 62.Wang Z, Wang S, Goplen NP, Li C, Cheon IS, Dai Q, Huang S, Shan J, Ma C, Ye Z, et al. : PD-1 hi CD8 + resident memory T cells balance immunity and fibrotic sequelae. Sci Immunol 2019, 4:eaaw1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Weisberg S, Carpenter DJ, Chait M, Dogra P, Gartrell-Corrado RD, Chen AX, Campbell S, Liu W, Saraf P, Snyder ME, et al. : Tissue-Resident Memory T Cells Mediate Immune Homeostasis in the Human Pancreas Through the PD-1/PD-L1 Pathway. Cell Rep 2019, doi: 10.2139/ssrn.3445675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shwetank, Frost EL, Mockus TE, Ren HM, Toprak M, Lauver MD, Netherby-Winslow CS, Jin G, Cosby JM, Evavold BD, et al. : PD-1 dynamically regulates inflammation and development of brain-resident memory CD8 T cells during persistent viral encephalitis. Front Immunol 2019, 10:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES